<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">An Bras Dermatol</journal-id>
      <journal-id journal-id-type="iso-abbrev">An Bras Dermatol</journal-id>
      <journal-id journal-id-type="publisher-id">An Bras Dermatol</journal-id>
      <journal-title-group>
        <journal-title>Anais Brasileiros de Dermatologia</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0365-0596</issn>
      <issn pub-type="epub">1806-4841</issn>
      <publisher>
        <publisher-name>Sociedade Brasileira de Dermatologia</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">24346884</article-id>
      <article-id pub-id-type="pmc">3876021</article-id>
      <article-id pub-id-type="doi">10.1590/abd1806-4841.20132243</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Vulvoperineal Crohn's disease responsive to metronidazole<xref ref-type="fn" rid="fn01">*</xref>
</article-title>
        <trans-title-group xml:lang="pt">
          <trans-title>Doen&#xE7;a de Crohn vulvoperineal responsiva ao metronidazol </trans-title>
        </trans-title-group>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Rosmaninho</surname>
            <given-names>Arist&#xF3;teles</given-names>
          </name>
          <xref ref-type="aff" rid="aff01">1</xref>
          <xref ref-type="corresp" rid="c01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Sanches</surname>
            <given-names>Madalena</given-names>
          </name>
          <xref ref-type="aff" rid="aff02">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Salgado</surname>
            <given-names>Marta</given-names>
          </name>
          <xref ref-type="aff" rid="aff03">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Alves</surname>
            <given-names>Ros&#xE1;rio</given-names>
          </name>
          <xref ref-type="aff" rid="aff01">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Selores</surname>
            <given-names>Manuela</given-names>
          </name>
          <xref ref-type="aff" rid="aff04">4</xref>
        </contrib>
      </contrib-group>
      <aff id="aff01"><label>1</label> MD - Hospital Assistant of Dermatovenereology at the Hospital de Santo
Ant&#xF3;nio - Hospital Center at Porto, E.P.E - Porto, Portugal.</aff>
      <aff id="aff02"><label>2</label> MD - Graduate Assistant of Dermatovenereology at the Hospital de Santo
Ant&#xF3;nio - Hospital Center at Porto, E.P.E - Porto, Portugal.</aff>
      <aff id="aff03"><label>3</label> MD - Hospital Assistant of Gastroenterology at the Hospital de Santo
Ant&#xF3;nio - Hospital Center at Porto, E.P.E - Porto, Portugal.</aff>
      <aff id="aff04"><label>4</label> MD - Director of the Dermatovenereology Service at the Hospital de
Santo Ant&#xF3;nio - Hospital Center at Porto, E.P.E - Porto, Portugal.</aff>
      <author-notes>
        <corresp id="c01"><bold>Mailing address:</bold> Arist&#xF3;teles Rosmaninho Rua D. Manuel II, s/n&#xBA; Edif&#xED;cio
da Consultas Externas 4099-001 - Porto - Portugal E-mail:
<email>arisrosmaninho@gmail.com</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <season>Nov-Dec</season>
        <year>2013</year>
      </pub-date>
      <volume>88</volume>
      <issue>6 Suppl 1</issue>
      <fpage>71</fpage>
      <lpage>74</lpage>
      <history>
        <date date-type="received">
          <day>21</day>
          <month>11</month>
          <year>2012</year>
        </date>
        <date date-type="accepted">
          <day>11</day>
          <month>1</month>
          <year>2013</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9;2013 by Anais Brasileiros de Dermatologia</copyright-statement>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">
          <license-p>This is an Open Access article distributed under the terms of the Creative
Commons Attribution Non-Commercial License, which permits unrestricted
non-commercial use, distribution, and reproduction in any medium, provided the
original work is properly cited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Crohn's disease is a multisystem chronic granulomatous inflammatory disease that
primarily affects the gastrointestinal tract. In the majority of the cases, the
cutaneous manifestations follow the intestinal disease, but occasionally
dermatological lesions are the inaugural event and may constitute the only sign of
the disease. Vulvoperineal involvement is rare, may precede bowel symptoms by months
to years and may go unrecognized. Due to the paucity of reports of Crohn's disease at
this location and in the absence of randomized trials, there are no standard
treatments for the cutaneous disease. We describe the case of a 47 year-old woman
with vulvoperineal Crohn's disease without digestive involvement, that was
successfully managed with metronidazole.</p>
      </abstract>
      <trans-abstract xml:lang="pt">
        <p>A doen&#xE7;a de Crohn &#xE9; uma doen&#xE7;a granulomatosa multissist&#xEA;mica inflamat&#xF3;ria cr&#xF3;nica que
afecta primariamente o tracto gastrointestinal. Na maioria dos casos, as
manifesta&#xE7;&#xF5;es cut&#xE2;neas sucedem a doen&#xE7;a intestinal, mas, ocasionalmente, as les&#xF5;es
dermatol&#xF3;gicas s&#xE3;o o primeiro evento e podem constituir o &#xFA;nico sinal da doen&#xE7;a. O
envolvimento vulvoperineal &#xE9; raro, pode preceder os sintomas intestinais em meses ou
anos, e pode passar despercebido. Devido &#xE0; escassez de relatos de doen&#xE7;a de Crohn com
esta localiza&#xE7;&#xE3;o e na aus&#xEA;ncia de ensaios cl&#xED;nicos randomizados, n&#xE3;o h&#xE1; nenhum
tratamento padr&#xE3;o para a doen&#xE7;a cut&#xE2;nea. Descrevemos um caso de uma mulher de 47 anos
com doen&#xE7;a de Crohn vulvoperineal sem envolvimento digestivo, que foi tratada com
sucesso com metronidazol.</p>
      </trans-abstract>
      <kwd-group>
        <kwd>Crohn disease</kwd>
        <kwd>Metronidazole</kwd>
        <kwd>Therapeutics</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>INTRODUCTION</title>
      <p>Crohn's disease is a multisystem chronic granulomatous inflammatory disease that
primarily affects the gastrointestinal tract. In the majority of cases, cutaneous
manifestations follow the intestinal disease, but occasionally dermatological lesions
are the inaugural event and may constitute the only sign of the disease. Vulvoperineal
involvement is rare, may precede bowel symptoms by months to years and may go
unrecognized. Due to the paucity of reports of Crohn's disease at this location and in
the absence of randomized trials, there are no standard treatments for the cutaneous
disease. Numerous therapies (including surgery, use of antibiotics and
immunosuppression) have been used with variable results. There are only anecdotal
reports that support the use of metronidazole. We describe a case of a 47 year-old woman
with vulvoperineal Crohn's disease without digestive involvement that was successfully
managed with metronidazole and without side effects. Oral metronidazole seems to be
effective in the treatment of vulvoperineal Crohn's disease and cutaneous flares also
respond rapidly to repeated treatment. </p>
    </sec>
    <sec>
      <title>CASE REPORT</title>
      <p>A 47-year-old woman presented for evaluation of multiple persistent painful
vulvoperineal lesions that had appeared in the last 5 years. She went on several
antibiotic courses without any improvement. She denied bowel complaints or weight loss.
Her past medical history was only remarkable for hypertension. On physical examination,
an exuberant inflammation of the vulva with aftoid ulcers of the labia minor and majora,
and linear ulcerations in the inguinocrural folds were observed. A deep linear fissure
above the clitoris and a "knife-cut" ulcer with sharp margins on the buttocks fold were
also present (<xref ref-type="fig" rid="f01">Figure 1</xref>). A skin biopsy revealed an
ulcerated epidermis with a fistulous tract and aspects of chronic inflammation with
lymphocytes, hystiocytes and multinucleated giant cells in a non- caseating
granulomatous pattern on the dermis (<xref ref-type="fig" rid="f02">Figure 2</xref>).
Fungal and mycobacterial elements were not detected by histology or in tissue culture.
Laboratory investigations were normal except for C-reactive protein of 41 mg/dl (&lt;5).
Syphilis, HIV serologies and Mantoux test were negative. PCR testing for herpes simplex
virus was negative. Chest X-ray showed no abnormalities. Based on the clinical and
histological findings a vulvoperineal cutaneous Crohn's disease (CD) diagnosis was made.
The patient was referred to gastroenterology for evaluation of bowel involvement.
Endoscopic studies of the digestive tract and biopsies from the ileum, colon and rectum
showed no abnormalities, so that a diagnosis of vulvoperineal cutaneous CD without
digestive involvement was assumed. The patient went on daily metronidazole (1000 mg) and
ciprofloxacin (1000 mg) with a striking improvement. Antibiotherapy was discontinued at
3 months and azathioprine (50 mg daily) was introduced. However, the condition worsened
and metronidazole (1000 mg daily) was added to azathioprine and marked improvement was
observed after 12 days. At 2 months of combined therapy (metronidazole 1000 mg plus
azathioprine 150 mg daily) sustained clinical improvement was observed (<xref ref-type="fig" rid="f03">Figure 3</xref>). </p>
      <fig id="f01" orientation="portrait" position="float">
        <label>FIGURE 1</label>
        <caption>
          <p>Clinical findings at presentation</p>
        </caption>
        <graphic xlink:href="abd-88-06-s1-0071-g01"/>
      </fig>
      <fig id="f02" orientation="portrait" position="float">
        <label>FIGURE 2</label>
        <caption>
          <p>H&amp;E (10x): ulcerated epidermis with a fistulous tract (left). PAS (40x):
aspects of chronic inflammation in a granulomatous pattern in the dermis
(right)</p>
        </caption>
        <graphic xlink:href="abd-88-06-s1-0071-g02"/>
      </fig>
      <fig id="f03" orientation="portrait" position="float">
        <label>FIGURE 3</label>
        <caption>
          <p>Clinical improvement with metronidazole and azathioprine at 2 months of
therapy</p>
        </caption>
        <graphic xlink:href="abd-88-06-s1-0071-g03"/>
      </fig>
    </sec>
    <sec sec-type="discussion">
      <title>DISCUSSION</title>
      <p>In CD the mucocutaneous lesions usually follow the intestinal disease and exceptionally
occur prior to bowel involvement.<sup><xref ref-type="bibr" rid="r01">1</xref></sup> In
the latter case, a high index of suspicion may be required to reach the accurate
diagnosis. Most of the lesions are a result of direct extension of the intestinal
disease (perineal abscesses and fistula) and more rarely they occur in a noncontiguous
extraintestinal spread (metastatic CD). Genitalia involvement in CD is rare.<sup><xref ref-type="bibr" rid="r02">2</xref>,<xref ref-type="bibr" rid="r03">3</xref></sup>
Andreani <italic>et al</italic>, reported that 25% of vulvar CD did not have any
previous intestinal symptoms and patients had not been diagnosed as having CD.<sup><xref ref-type="bibr" rid="r02">2</xref></sup> Vulvar swelling, erythema and pain that
evolve to vulvar hypertrophy, ulceration and abscesses are the typical clinical picture.
"Knifecut" ulcers (as in our case) are almost pathognomonic of CD, although they have
been described in cutaneous tuberculosis and herpetic infections in immunocompromised
patients.<sup><xref ref-type="bibr" rid="r03">3</xref></sup> The histological
examination characteristically shows non-caseating granulomas. The differential
diagnoses include other granulomatous diseases that can cause vulvar ulceration such as
sarcoidosis, tuberculosis, fungal infections, lymphogranuloma venereum, granuloma
inguinale and actinomycosis. Sometimes pyoderma gangrenosum can clinically mimic
cutaneous Crohn's disease. Ruling out infections usually requires bacteriological and
mycological workup. Due to a paucity of reports with this topography the treatment
remains nonstandardized.<sup><xref ref-type="bibr" rid="r04">4</xref></sup> Several
medical treatments for cutaneous disease have been proposed with variable results and
include: topical, intralesional and systemic corticosteroids, sulfasalazine,
azathioprine, cyclosporine, methotrexate, thalidomide, metronidazole, infliximab,
adalimumab and surgical excision. Only few small studies and anecdotal reports have
evaluated the use of metronidazole.<sup><xref ref-type="bibr" rid="r02">2</xref>,<xref ref-type="bibr" rid="r03">3</xref>,<xref ref-type="bibr" rid="r04">4</xref>-<xref ref-type="bibr" rid="r07">7</xref></sup> As supported by our case, it seems to be
effective with resolution of almost all the lesions. In combination with oral
corticotherapy a success rate of 87.5% has been reported.<sup><xref ref-type="bibr" rid="r02">2</xref></sup> Its efficacy is probably due to its anti-inflammatory,
antibacterial and immunosuppressive action.<sup><xref ref-type="bibr" rid="r04">4</xref></sup> In the study of Brandt LJ <italic>et al</italic>, the lesions of all
26 patients with perineal CD cleared, and an optimal dose of 20 mg/kg/day for 12 to 36
months was required.<sup><xref ref-type="bibr" rid="r08">8</xref></sup> The tapering of
this dose often leads to recurrences, however cutaneous lesions promptly respond to
repeated treatment with the drug.<sup><xref ref-type="bibr" rid="r05">5</xref>,<xref ref-type="bibr" rid="r08">8</xref></sup> Reversible paresthesia is the major
complication reported with long-term metronidazole therapy.<sup><xref ref-type="bibr" rid="r04">4</xref></sup> Minor complications include a metallic taste and
darkening of the urine together with gastrointestinal upset. In our patient the
treatment was well-tolerated without any side effects. We report an extremely atypical
presentation of CD that was successfully managed with metronidazole with no significant
adverse effects. Physicians should be aware of such presentation as it may precede
gastrointestinal involvement and be a cause of high morbidity if not promptly
recognized.</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn id="fn01" fn-type="other">
        <p>* Work performed at the Dermatology Service; Hospital de Santo Ant&#xF3;nio - Hospital
Center at Porto, E.P.E - Porto, Portugal.</p>
      </fn>
      <fn id="fn02" fn-type="financial-disclosure">
        <p>Financial Support: none</p>
      </fn>
      <fn id="fn03" fn-type="conflict">
        <p>Conflict of Interests: none</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>REFERENCES </title>
      <ref id="r01">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Eames</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Landthaler</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Karrer</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Crohn's disease: an important differential diagnosis of granulomatous
skin diseases</article-title>
          <source>Eur J Dermatol</source>
          <year>2009</year>
          <volume>19</volume>
          <fpage>360</fpage>
          <lpage>364</lpage>
          <pub-id pub-id-type="pmid">19443301</pub-id>
        </element-citation>
      </ref>
      <ref id="r02">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Andreani</surname>
              <given-names>SM</given-names>
            </name>
            <name>
              <surname>Ratnasingham</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Dang</surname>
              <given-names>HH</given-names>
            </name>
            <name>
              <surname>Gravante</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Giordano</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Crohn's disease of the vulva</article-title>
          <source>Int J Surg</source>
          <year>2010</year>
          <volume>8</volume>
          <fpage>2</fpage>
          <lpage>5</lpage>
          <pub-id pub-id-type="pmid">19800432</pub-id>
        </element-citation>
      </ref>
      <ref id="r03">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Madnani</surname>
              <given-names>NA</given-names>
            </name>
            <name>
              <surname>Desai</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Gandhi</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Khan</surname>
              <given-names>KJ</given-names>
            </name>
          </person-group>
          <article-title>Isolated Crohn's disease of the vulva</article-title>
          <source>Indian J Dermatol Venereol Leprol</source>
          <year>2011</year>
          <volume>77</volume>
          <fpage>342</fpage>
          <lpage>344</lpage>
          <pub-id pub-id-type="pmid">21508582</pub-id>
        </element-citation>
      </ref>
      <ref id="r04">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Khaled</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Ezzine-Sebai</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Fazaa</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Zeglaoui</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Zermani</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Kamoun</surname>
              <given-names>MR</given-names>
            </name>
          </person-group>
          <article-title>Vulvoperineal Crohn's disease: response to
metronidazole</article-title>
          <source>Skinmed</source>
          <year>2010</year>
          <volume>8</volume>
          <fpage>240</fpage>
          <lpage>241</lpage>
          <pub-id pub-id-type="pmid">21137614</pub-id>
        </element-citation>
      </ref>
      <ref id="r05">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Abide</surname>
              <given-names>JM</given-names>
            </name>
          </person-group>
          <article-title>Metastatic Crohn disease: clearance with metronidazole</article-title>
          <source>J Am Acad Dermatol</source>
          <year>2011</year>
          <volume>64</volume>
          <fpage>448</fpage>
          <lpage>449</lpage>
          <pub-id pub-id-type="pmid">21238840</pub-id>
        </element-citation>
      </ref>
      <ref id="r06">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Thukral</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Travassos</surname>
              <given-names>WJ</given-names>
            </name>
            <name>
              <surname>Peppercorn</surname>
              <given-names>MA</given-names>
            </name>
          </person-group>
          <article-title>The role of antibiotics in inflammatory bowel disease</article-title>
          <source>Curr Treat Options Gastroenterol</source>
          <year>2005</year>
          <volume>8</volume>
          <fpage>223</fpage>
          <lpage>228</lpage>
          <pub-id pub-id-type="pmid">15913511</pub-id>
        </element-citation>
      </ref>
      <ref id="r07">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fernandes</surname>
              <given-names>MD</given-names>
            </name>
            <name>
              <surname>Fernandes</surname>
              <given-names>HD</given-names>
            </name>
            <name>
              <surname>Deliza</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Pires</surname>
              <given-names>CE</given-names>
            </name>
            <name>
              <surname>Bortoncello</surname>
              <given-names>AC</given-names>
            </name>
          </person-group>
          <article-title>Metastatic Crohn's disease without intestinal clinical
manifestation</article-title>
          <source>An Bras Dermatol</source>
          <year>2009</year>
          <volume>84</volume>
          <fpage>651</fpage>
          <lpage>654</lpage>
          <pub-id pub-id-type="pmid">20191177</pub-id>
        </element-citation>
      </ref>
      <ref id="r08">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Brandt</surname>
              <given-names>LJ</given-names>
            </name>
            <name>
              <surname>Bernstein</surname>
              <given-names>LH</given-names>
            </name>
            <name>
              <surname>Boley</surname>
              <given-names>SJ</given-names>
            </name>
            <name>
              <surname>Frank</surname>
              <given-names>MS</given-names>
            </name>
          </person-group>
          <article-title>Metronidazole therapy for perineal Crohn's disease: a follow-up
study</article-title>
          <source>Gastroenterology</source>
          <year>1982</year>
          <volume>83</volume>
          <fpage>383</fpage>
          <lpage>387</lpage>
          <pub-id pub-id-type="pmid">7084615</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
